Bergthora Sigridur Snorradottir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bergthora Sigridur Snorradottir has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Fjola Jonsdottir
Faculty of Industrial Engineering, Mechanical Engineering and Computer Science, University of Iceland, 107 Reykjavik, Iceland
3 shared publications - Helena Hamzehpour
Faculty of Pharmaceutical Sciences, University of Iceland, 107 Reykjavik, Iceland
2 shared publications - Helgi Jonsson
Faculty of Medicine, University of Iceland, 107 Reykjavik, Iceland
2 shared publications - Karin Wuertz-Kozak
Department of Biomedical Engineering Rochester Institute of Technology Rochester New York USA
2 shared publications - Oddny Bjorgvinsdottir
Faculty of Pharmaceutical Sciences, University of Iceland, Hofsvallagata 53, 107 Reykjavik, Iceland
2 shared publications - Stephen J. Ferguson
Future Health Technologies, Singapore-ETH Centre, Campus for Research Excellence And Technological Enterprise (CREATE)
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8785
Direct Integration of Electrospun Polycaprolactone Fibers with Polydimethylsiloxane: Influence of Elastomer Formulation on Fiber–Elastomer Adhesion
The increasing use of complex medical devices has intensified the need for reliable integration of multiple biocompatible materials. Silicone elastomers are widely used in implantable devices and frequently combined with materials designed to support cell growth. In such hybrid systems, robust interfacial adhesion is essential for mechanical stability and functional performance. In this study, electrospun poly(ε-caprolactone) (PCL) fibers were deposited directly onto two silicone elastomers, RTV 4420 and Sylgard 184, to form mechanically integrated bilayer structures. Adhesion of the electrospun PCL membrane to the silicone substrates was evaluated using a 180° peel test, while fiber morphology and surface topography were characterized to investigate the influence of the substrate material. The mean steady-state adhesive strength measured for the electrospun PCL membrane and RTV 4420 was 4.76 ± 0.05 mN/mm (mean ± SEM), compared with 6.83 ± 1.49 mN/mm for Sylgard 184. Distinct differences in residual bead formation and fiber morphology were observed between fibers collected on polydimethylsiloxane (PDMS) and aluminum foil. Fiber diameter differed significantly when spun onto uncured Sylgard 184 compared with uncured RTV 4420 or aluminum foil. Additionally, high-voltage electrospinning induced transient surface structures in the uncured silicone that were retained in the fiber pattern after voltage removal. Overall, direct electrospinning enabled PCL–silicone adhesion while providing control over fiber morphology, offering a promising approach for developing stable, cell-supporting interfaces in research and medical devices.
- 30 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8785
Open AccessDirect Integration of Electrospun Polycaprolactone Fibers with Polydimethylsiloxane: Influence of Elastomer Formulation on Fiber–Elastomer Adhesion
The increasing use of complex medical devices has intensified the need for reliable integration of multiple biocompatible materials. Silicone elastomers are widely used in implantable devices and frequently combined with materials designed to support cell growth. In such hybrid systems, robust interfacial adhesion is essential for mechanical stability and functional performance. In this study, electrospun poly(ε-caprolactone) (PCL) fibers were deposited directly onto two silicone elastomers, RTV 4420 and Sylgard 184, to form mechanically integrated bilayer structures. Adhesion of the electrospun PCL membrane to the silicone substrates was evaluated using a 180° peel test, while fiber morphology and surface topography were characterized to investigate the influence of the substrate material. The mean steady-state adhesive strength measured for the electrospun PCL membrane and RTV 4420 was 4.76 ± 0.05 mN/mm (mean ± SEM), compared with 6.83 ± 1.49 mN/mm for Sylgard 184. Distinct differences in residual bead formation and fiber morphology were observed between fibers collected on polydimethylsiloxane (PDMS) and aluminum foil. Fiber diameter differed significantly when spun onto uncured Sylgard 184 compared with uncured RTV 4420 or aluminum foil. Additionally, high-voltage electrospinning induced transient surface structures in the uncured silicone that were retained in the fiber pattern after voltage removal. Overall, direct electrospinning enabled PCL–silicone adhesion while providing control over fiber morphology, offering a promising approach for developing stable, cell-supporting interfaces in research and medical devices.
- Open Access
- 14 October 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (10) , 1333
A Four-Layer Numerical Model for Transdermal Drug Delivery: Parameter Optimization and Experimental Validation Using a Franz Diffusion Cell
Background/Objectives: A mechanistic understanding of transdermal drug delivery relies on accurately capturing the layered structure and barrier function of the skin. This study presents a four-layer numerical model that explicitly includes the donor compartment, stratum corneum (SC), viable skin (RS), and receptor compartment. Methods: The model is based on Fickian diffusion and incorporates interfacial partitioning and mass transfer resistance. It is implemented using the finite element method in MATLAB and calibrated through nonlinear least-squares optimization against experimental data from Franz diffusion cell studies using porcine skin. Validation was performed using receptor concentration profiles over time and final drug content in the SC and RS layers, assessed via tape stripping and residual skin analysis. Results: The model provided excellent agreement with experimental data. For diclofenac, the optimized partition coefficient at the SC–RS interface was close to unity, indicating minimal interfacial discontinuity and that a simplified three-layer model may be sufficient for this compound. Conclusions: The proposed four-layer framework provides a physiologically informed and generalizable platform for simulating transdermal drug delivery. It enables spatial resolution, mechanistic interpretation, and flexible adaptation to other drugs and formulations, particularly those with significant interfacial effects or limited lipophilicity.
- 14 October 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (10) , 1333
Open AccessA Four-Layer Numerical Model for Transdermal Drug Delivery: Parameter Optimization and Experimental Validation Using a Franz Diffusion Cell
Background/Objectives: A mechanistic understanding of transdermal drug delivery relies on accurately capturing the layered structure and barrier function of the skin. This study presents a four-layer numerical model that explicitly includes the donor compartment, stratum corneum (SC), viable skin (RS), and receptor compartment. Methods: The model is based on Fickian diffusion and incorporates interfacial partitioning and mass transfer resistance. It is implemented using the finite element method in MATLAB and calibrated through nonlinear least-squares optimization against experimental data from Franz diffusion cell studies using porcine skin. Validation was performed using receptor concentration profiles over time and final drug content in the SC and RS layers, assessed via tape stripping and residual skin analysis. Results: The model provided excellent agreement with experimental data. For diclofenac, the optimized partition coefficient at the SC–RS interface was close to unity, indicating minimal interfacial discontinuity and that a simplified three-layer model may be sufficient for this compound. Conclusions: The proposed four-layer framework provides a physiologically informed and generalizable platform for simulating transdermal drug delivery. It enables spatial resolution, mechanistic interpretation, and flexible adaptation to other drugs and formulations, particularly those with significant interfacial effects or limited lipophilicity.
- Open Access
- 9 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 489
Optimization and Validation of an Ultra-Performance Liquid Chromatography with Quadrupole Detector Mass Spectrometry Quantification Method for the Simultaneous Detection of Tazarotene and Tazarotenic Acid in Porcine Skin: An In Vitro Study
Exploring tazarotene, a third-generation retinoid for potential hand osteoarthritis treatment, this study presents the development and validation of an ultra-performance liquid chromatography with quadrupole detector mass spectrometry (UPLC-QDa) method for the simultaneous quantification of tazarotene and tazarotenic acid, its active metabolite, in porcine skin. Method development involved a design-of-experiments approach for chromatographic optimization of gradient steepness, organic solvent volume, column temperature, capillary voltage, flow rate, and cone voltage. Central composite orthogonal design was used to optimize peak area, peak width, retention time, and resolution. Validation was performed in accordance with U.S. Food and Drug Administration guidelines. The method was linear over the concentration range of 0.4–18,750 ng/mL for tazarotene and 13.3–12,500 ng/mL for tazarotenic acid, with r2 values of ≥0.99. Chromatographic analysis demonstrated acceptable accuracy and precision (<15%), and stability tests confirmed the analytes’ stability under various conditions. This validated method offers a reliable and accurate approach for the simultaneous analysis of tazarotene and tazarotenic acid, facilitating further research into their therapeutic applications for hand osteoarthritis.
- 9 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 489
Open AccessOptimization and Validation of an Ultra-Performance Liquid Chromatography with Quadrupole Detector Mass Spectrometry Quantification Method for the Simultaneous Detection of Tazarotene and Tazarotenic Acid in Porcine Skin: An In Vitro Study
Exploring tazarotene, a third-generation retinoid for potential hand osteoarthritis treatment, this study presents the development and validation of an ultra-performance liquid chromatography with quadrupole detector mass spectrometry (UPLC-QDa) method for the simultaneous quantification of tazarotene and tazarotenic acid, its active metabolite, in porcine skin. Method development involved a design-of-experiments approach for chromatographic optimization of gradient steepness, organic solvent volume, column temperature, capillary voltage, flow rate, and cone voltage. Central composite orthogonal design was used to optimize peak area, peak width, retention time, and resolution. Validation was performed in accordance with U.S. Food and Drug Administration guidelines. The method was linear over the concentration range of 0.4–18,750 ng/mL for tazarotene and 13.3–12,500 ng/mL for tazarotenic acid, with r2 values of ≥0.99. Chromatographic analysis demonstrated acceptable accuracy and precision (<15%), and stability tests confirmed the analytes’ stability under various conditions. This validated method offers a reliable and accurate approach for the simultaneous analysis of tazarotene and tazarotenic acid, facilitating further research into their therapeutic applications for hand osteoarthritis.
- Open Access
- 18 April 2024
- Published by Elsevier in Materials Today Bio
- Vol. 26, 101060
The influence of physical and spatial substrate characteristics on endothelial cells
- 18 April 2024
- Published by Elsevier in Materials Today Bio
- Vol. 26, 101060
Open AccessThe influence of physical and spatial substrate characteristics on endothelial cells
- Open Access
- 31 December 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 64
Transdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy
Retinoid-based drugs, while effective, are associated with systemic toxicity. Topical alternatives offer a safer option, and tazarotene, a third-generation synthetic retinoid, holds promise. This study investigates tazarotene’s transdermal delivery potential, focusing on its application for joint-related conditions. The aim of this study was to investigate the suitability of tazarotene as a candidate for transdermal delivery into joints. In vitro permeation studies, using porcine skin, assessed tazarotene’s transdermal drug delivery from solution and gel formulations. A tape-stripping analysis determined stratum corneum retention and a pilot study using porcine joints assessed tazarotene’s ability to reach articular cartilage. Ultra Performance Liquid Chromatography coupled with a mass detector method was used to quantify tazarotene and tazarotenic acid permeation. The results validate that tazarotene can permeate porcine skin and accumulate in articular cartilage in detectable amounts. The detection of tazarotene and tazarotenic acid in both the in vitro permeation studies and the pilot study on porcine joints validate the drug’s potential therapeutic use for hand osteoarthritis. This study lays the groundwork for future research, contributing insights into tazarotene’s potential for transdermal drug delivery and guiding further exploration in topical retinoid applications.
- 31 December 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (1) , 64
Open AccessTransdermal Drug Delivery of Tazarotene: Determining Tazarotene’s Potential in Local Transdermal Therapy
Retinoid-based drugs, while effective, are associated with systemic toxicity. Topical alternatives offer a safer option, and tazarotene, a third-generation synthetic retinoid, holds promise. This study investigates tazarotene’s transdermal delivery potential, focusing on its application for joint-related conditions. The aim of this study was to investigate the suitability of tazarotene as a candidate for transdermal delivery into joints. In vitro permeation studies, using porcine skin, assessed tazarotene’s transdermal drug delivery from solution and gel formulations. A tape-stripping analysis determined stratum corneum retention and a pilot study using porcine joints assessed tazarotene’s ability to reach articular cartilage. Ultra Performance Liquid Chromatography coupled with a mass detector method was used to quantify tazarotene and tazarotenic acid permeation. The results validate that tazarotene can permeate porcine skin and accumulate in articular cartilage in detectable amounts. The detection of tazarotene and tazarotenic acid in both the in vitro permeation studies and the pilot study on porcine joints validate the drug’s potential therapeutic use for hand osteoarthritis. This study lays the groundwork for future research, contributing insights into tazarotene’s potential for transdermal drug delivery and guiding further exploration in topical retinoid applications.
- Open Access
- 27 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1076
Estimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach
Most of the individuals who die of malaria in sub–Saharan Africa are children. It is, therefore, important for this age group to have access to the right treatment and correct dose. Artemether—lumefantrine is one of the fixed dose combination therapies that was approved by the World Health Organization to treat malaria. However, the current recommended dose has been reported to cause underexposure or overexposure in some children. The aim of this article was, therefore, to estimate the doses that can mimic adult exposure. The availability of more and reliable pharmacokinetic data is essential to accurately estimate appropriate dosage regimens. The doses in this study were estimated using the physiological information from children and some pharmacokinetic data from adults due to the lack of pediatric pharmacokinetic data in the literature. Depending on the approach that was used to calculate the dose, the results showed that some children were underexposed, and others were overexposed. This can lead to treatment failure, toxicity, and even death. Therefore, when designing a dosage regimen, it is important to know and include the distinctions in physiology at various phases of development that influence the pharmacokinetics of various drugs in order to estimate the dose in young children. The physiology at each time point during the growth of a child may influence how the drug is absorbed, gets distributed, metabolized, and eliminated. From the results, there is a very clear need to conduct a clinical study to further verify if the suggested (i.e., 0.34 mg/kg for artemether and 6 mg/kg for lumefantrine) doses could be clinically efficacious.
- 27 March 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1076
Open AccessEstimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach
Most of the individuals who die of malaria in sub–Saharan Africa are children. It is, therefore, important for this age group to have access to the right treatment and correct dose. Artemether—lumefantrine is one of the fixed dose combination therapies that was approved by the World Health Organization to treat malaria. However, the current recommended dose has been reported to cause underexposure or overexposure in some children. The aim of this article was, therefore, to estimate the doses that can mimic adult exposure. The availability of more and reliable pharmacokinetic data is essential to accurately estimate appropriate dosage regimens. The doses in this study were estimated using the physiological information from children and some pharmacokinetic data from adults due to the lack of pediatric pharmacokinetic data in the literature. Depending on the approach that was used to calculate the dose, the results showed that some children were underexposed, and others were overexposed. This can lead to treatment failure, toxicity, and even death. Therefore, when designing a dosage regimen, it is important to know and include the distinctions in physiology at various phases of development that influence the pharmacokinetics of various drugs in order to estimate the dose in young children. The physiology at each time point during the growth of a child may influence how the drug is absorbed, gets distributed, metabolized, and eliminated. From the results, there is a very clear need to conduct a clinical study to further verify if the suggested (i.e., 0.34 mg/kg for artemether and 6 mg/kg for lumefantrine) doses could be clinically efficacious.
- Open Access
- 6 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1880
Transdermal Drug Delivery: Determining Permeation Parameters Using Tape Stripping and Numerical Modeling
The function of transdermal drug delivery (TDD) systems is complex due to the multiple layers necessary for controlling the rate of drug release and the interaction with the patient’s skin. In this work, we study a particular aspect of a TDD system, that is, the parameters that describe the drug permeation through the skin layers. Studies of the diffusion of two compounds were carried out and supported by tape stripping and numerical modeling. The experimental studies are carried out for porcine skin in a Franz diffusion cell and tape stripping is used to quantify the concentration of drug in the stratum corneum. A multi-layered numerical model, based on Fickian diffusion, is used to determine the unknown parameters that define the skin’s permeability, such as the partition between layers and the mass transfer coefficients due to the surface barrier. A significant correlation was found between the numerical modeling and experimental results, indicating that the partition and mass transfer effects at the interlayer boundary are accurately represented in the numerical model. We find that numerical modeling is essential to fully describe the diffusion characteristics.
- 6 September 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1880
Open AccessTransdermal Drug Delivery: Determining Permeation Parameters Using Tape Stripping and Numerical Modeling
The function of transdermal drug delivery (TDD) systems is complex due to the multiple layers necessary for controlling the rate of drug release and the interaction with the patient’s skin. In this work, we study a particular aspect of a TDD system, that is, the parameters that describe the drug permeation through the skin layers. Studies of the diffusion of two compounds were carried out and supported by tape stripping and numerical modeling. The experimental studies are carried out for porcine skin in a Franz diffusion cell and tape stripping is used to quantify the concentration of drug in the stratum corneum. A multi-layered numerical model, based on Fickian diffusion, is used to determine the unknown parameters that define the skin’s permeability, such as the partition between layers and the mass transfer coefficients due to the surface barrier. A significant correlation was found between the numerical modeling and experimental results, indicating that the partition and mass transfer effects at the interlayer boundary are accurately represented in the numerical model. We find that numerical modeling is essential to fully describe the diffusion characteristics.
- 16 April 2022
- Published by Elsevier in Phytochemistry
- Vol. 200, 113210
Novel methods to characterise spatial distribution and enantiomeric composition of usnic acids in four Icelandic lichens
- 16 April 2022
- Published by Elsevier in Phytochemistry
- Vol. 200, 113210
Novel methods to characterise spatial distribution and enantiomeric composition of usnic acids in four Icelandic lichens